Literature DB >> 29952729

Meningococcal serogroup B outbreak response University of Wisconsin-Madison.

Alicia M Ritscher1, Nancy Ranum2, Joel D Malak2, Susann Ahrabi-Fard3, Jennifer Baird2, Andrew D Berti1, William Curtis4, Marlena Holden2, Cheryl D Jones2, Jennifer Kind2, William Kinsey2, Ruth Koepke3, Stephanie L Schauer3, Elizabeth Stein5, Sarah Van Orman2, Brian G Ward6, Susan J Zahner7, Mary S Hayney1.   

Abstract

A meningococcal serogroup B (MenB) outbreak at a large public university prompted an emergency response to immunize undergraduates.
OBJECTIVE: To report on a successful meningococcal serogroup B (MenB) vaccine clinic response at a large public university.
METHODS: We assembled the team leaders to write this case report.
RESULTS: Activation of the emergency plan and points of dispensing required cooperation of many units on campus under the leadership of university health officials with support from Centers for Disease Control and Prevention, state division of public health and the city-county health department. Significant efforts to provide consistent messages to students and parents regarding the outbreak and the availability of the MenB vaccines were made. Volunteers were recruited to staff the clinics alongside university healthcare providers. Over 22,000 doses of vaccine were administered.
CONCLUSION: We report our experience and lessons learned which may be helpful to universities in preventing and responding to disease outbreaks.

Entities:  

Keywords:  Emergency response; outbreak; points of dispensing; serogroup B meninogococcus; student health; university; vaccine

Mesh:

Substances:

Year:  2018        PMID: 29952729     DOI: 10.1080/07448481.2018.1469502

Source DB:  PubMed          Journal:  J Am Coll Health        ISSN: 0744-8481


  3 in total

1.  Increasing awareness and uptake of the MenB vaccine on a large university campus.

Authors:  Eric Richardson; Kathleen A Ryan; Robert M Lawrence; Christopher A Harle; Shivani M Desai; Melvin D Livingston; Amit Rawal; Stephanie A S Staras
Journal:  Hum Vaccin Immunother       Date:  2021-06-02       Impact factor: 4.526

2.  University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018.

Authors:  Heidi M Soeters; Lucy A McNamara; Amy E Blain; Melissa Whaley; Jessica R MacNeil; Susan Hariri; Sarah A Mbaeyi
Journal:  Emerg Infect Dis       Date:  2019-03       Impact factor: 6.883

3.  Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada1.

Authors:  Joanne M Langley; Soren Gantt; Caroline Quach; Julie A Bettinger; Scott A Halperin; Jill Mutch; Shelly A McNeil; Brian J Ward; Donna MacKinnon-Cameron; Lingyun Ye; Kim Marty; David Scheifele; Erin Brown; Joenel Alcantara
Journal:  Emerg Infect Dis       Date:  2020-03       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.